Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients

Acute Effects of Very-Low-Protein Diet on FGF23 Levels: A Randomized Study

(2012) B. Di Iorio et al.   Clinical Journal of the American Society of Nephrology

Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease

(2011) Guido Filler et al.   CLINICAL BIOCHEMISTRY

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

(2011) Tamara Isakova et al.   KIDNEY INTERNATIONAL

Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the "Trade-off" Hypothesis

(2010) O. M. Gutierrez   Clinical Journal of the American Society of Nephrology

A new approach for evaluating bone turnover in chronic kidney disease

(2010) Ramin Tolouian et al.   European Journal of Internal Medicine

A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine

(2010) Dennis A. Hanson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men

(2010) Majd AI Mirza et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone Mass and Microarchitecture in CKD Patients with Fracture

(2010) T. L. Nickolas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Evidence-based Practice Guideline for the Treatment of CKD

(2009)   Clinical and Experimental Nephrology

Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

(2008) Hua Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis

(2008) Katherine Wesseling-Perry et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM